{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:32:36Z","timestamp":1791981156123,"version":"4.4.0"},"reference-count":222,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022955","name":"Fundamental Research Funds for the Provincial Universities of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Cancer Center"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jncc.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T16:50:43Z","timestamp":1726332643000},"page":"354-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Osteoimmunology in bone malignancies: a symphony with evil"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3923-8616","authenticated-orcid":false,"given":"Churui","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biqi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-9263","authenticated-orcid":false,"given":"Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6462-6067","authenticated-orcid":false,"given":"Weijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jncc.2024.09.001_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jncc.2024.09.001_bib0002","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u201cseed and soil\u201d hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0003","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone\u2013immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0004","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","article-title":"Osteoimmunology: the conceptual framework unifying the immune and skeletal systems","volume":"97","author":"Okamoto","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jncc.2024.09.001_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0006","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood-2014-09-570192","article-title":"Making sense of hematopoietic stem cell niches","volume":"125","author":"Boulais","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0008","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jncc.2024.09.001_bib0009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jncc.2024.09.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031252","article-title":"The biology of bone metastasis","volume":"8","author":"Esposito","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0011","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality \u2014 the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0012","first-page":"31","article-title":"The long and winding road: homeostatic and disordered haematopoietic microenvironmental niches: a narrative review","volume":"3","author":"Watt","year":"2022","journal-title":"Biomater Transl"},{"key":"10.1016\/j.jncc.2024.09.001_bib0013","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/35046196","article-title":"Bone versus immune system","volume":"408","author":"Arron","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0014","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","article-title":"Identification of the haematopoietic stem cell niche and control of the niche size","volume":"425","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0015","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood-2003-11-4011","article-title":"Hematopoiesis is severely altered in mice with an induced osteoblast deficiency","volume":"103","author":"Visnjic","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0016","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1182\/blood-2006-08-041384","article-title":"Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells","volume":"109","author":"Zhu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0017","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood.2020007731","article-title":"Osteocytes regulate neutrophil development through IL-19: a potent cytokine for neutropenia treatment","volume":"137","author":"Xiao","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0018","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1084\/jem.20141843","article-title":"Specific bone cells produce DLL4 to generate thymus-seeding progenitors from bone marrow","volume":"212","author":"Yu","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0019","doi-asserted-by":"crossref","first-page":"16976","DOI":"10.1073\/pnas.0802898105","article-title":"Osteoblastic regulation of B lymphopoiesis is mediated by G s\u03b1-dependent signaling pathways","volume":"105","author":"Wu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jncc.2024.09.001_bib0020","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2013-02-486217","article-title":"Mast cell and macrophage chemokines CXCL1\/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation","volume":"121","author":"De Filippo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/cmi.2011.47","article-title":"Bone marrow and the control of immunity","volume":"9","author":"Zhao","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0022","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2018.01.017","article-title":"CD150 high bone marrow Tregs maintain hematopoietic stem cell quiescence and immune privilege via adenosine","volume":"22","author":"Hirata","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0023","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1158\/0008-5472.CAN-04-1987","article-title":"Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12\/CXCR4 signals","volume":"64","author":"Zou","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0024","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches","volume":"495","author":"Ding","year":"2013","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.jncc.2024.09.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135681","article-title":"Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10","volume":"5","author":"Camacho","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jncc.2024.09.001_bib0026","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.immuni.2016.05.012","article-title":"Sepsis-induced osteoblast ablation causes immunodeficiency","volume":"44","author":"Terashima","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jncc.2024.09.001_bib0027","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","article-title":"Developmental origin, functional maintenance and genetic rescue of osteoclasts","volume":"568","author":"Jacome-Galarza","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0028","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.immunol.20.100301.064753","article-title":"RANK-L and RANK: t cells, bone loss, and mammalian evolution","volume":"20","author":"Theill","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.681171","article-title":"Mesenchymal stem cell-macrophage crosstalk and maintenance of inflammatory microenvironment homeostasis","volume":"9","author":"Lu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4049\/jimmunol.1601528","article-title":"IL-3 differentially regulates membrane and soluble RANKL in osteoblasts through metalloproteases and the JAK2\/STAT5 pathway and improves the RANKL\/OPG ratio in adult mice","volume":"200","author":"Singh","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0031","doi-asserted-by":"crossref","first-page":"15327","DOI":"10.1096\/fj.202001078R","article-title":"T cells participate in bone remodeling during the rapid palatal expansion","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jncc.2024.09.001_bib0032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0033","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","article-title":"Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow","volume":"15","author":"Zhou","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0034","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1038\/boneres.2016.9","article-title":"TGF-\u03b2 and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease","volume":"4","author":"Wu","year":"2016","journal-title":"Bone Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.598263","article-title":"Communications between bone marrow macrophages and bone cells in bone remodeling","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0036","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ajpath.2015.07.017","article-title":"Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis","volume":"185","author":"Kim","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0037","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","article-title":"RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation","volume":"75","author":"Danks","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jncc.2024.09.001_bib0038","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard-2022-223568","article-title":"Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis","volume":"82","author":"O'Neil","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jncc.2024.09.001_bib0039","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bph.16227","article-title":"Neutrophil extracellular traps mediate bone erosion in rheumatoid arthritis by enhancing RANKL-induced osteoclastogenesis","volume":"181","author":"Schneider","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0040","doi-asserted-by":"crossref","first-page":"e1429","DOI":"10.1002\/ctm2.1429","article-title":"Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma","volume":"13","author":"Huo","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0041","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41467-020-14646-w","article-title":"Immuno-genomic landscape of osteosarcoma","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jncc.2024.09.001_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/2162402X.2014.990800","article-title":"CD8+\/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study","volume":"4","author":"Fritzsching","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jncc.2024.09.001_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001772","article-title":"Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes","volume":"9","author":"Ligon","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0044","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-030-43085-6_2","article-title":"Genomics and the immune landscape of osteosarcoma","volume":"1258","author":"Wu","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0045","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.21037\/atm-21-3928","article-title":"T cell exhaustion drives osteosarcoma pathogenesis","volume":"9","author":"Sun","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0046","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1939-1676.2010.0557.x","article-title":"Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma","volume":"24","author":"Biller","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107417","article-title":"Deciphering the heterogeneity and immunosuppressive function of regulatory T cells in osteosarcoma using single-cell RNA transcriptome","volume":"165","author":"Cheng","year":"2023","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0048","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.yexcr.2017.07.011","article-title":"Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells","volume":"358","author":"Troyer","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0049","doi-asserted-by":"crossref","first-page":"30093","DOI":"10.1038\/srep30093","article-title":"Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma","volume":"6","author":"Koirala","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jncc.2024.09.001_bib0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2015.07.042","article-title":"Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner","volume":"368","author":"Fern\u00e1ndez","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jncc.2024.09.001_bib0051","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00262-012-1232-6","article-title":"Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients","volume":"61","author":"Buddingh","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jncc.2024.09.001_bib0052","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.jncc.2024.09.001_bib0053","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2230::AID-CNCR3>3.0.CO;2-Y","article-title":"Expression of transforming growth factor-\u03b2 (TGF-\u03b2) isoforms in osteosarcomas: tGF-\u03b23 is related to disease progression","volume":"80","author":"Kloen","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0054","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/jvim.12348","article-title":"Pro-tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma","volume":"28","author":"Portela","year":"2014","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0055","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2559.2008.02989.x","article-title":"Expression and roles of MICA in human osteosarcoma","volume":"52","author":"Xiao","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.jncc.2024.09.001_bib0056","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","article-title":"Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity","volume":"359","author":"De Andrade","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jncc.2024.09.001_bib0057","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.19132","article-title":"Exploration of immune-related gene expression in osteosarcoma and association with outcomes","volume":"4","author":"Liu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jncc.2024.09.001_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1026701","article-title":"Identification of B cell marker genes based on single-cell sequencing to establish a prognostic model and identify immune infiltration in osteosarcoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0059","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents","volume":"17","author":"Buddingh","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.canlet.2018.10.011","article-title":"Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2\/STAT3 axis","volume":"440\u2013441","author":"Han","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jncc.2024.09.001_bib0061","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41401-019-0262-4","article-title":"Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells","volume":"40","author":"jing","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jncc.2024.09.001_bib0062","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.intimp.2016.01.023","article-title":"CD163 + M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma","volume":"34","author":"Han","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0063","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1038\/s41467-022-34064-4","article-title":"Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jncc.2024.09.001_bib0064","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0065","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105818","article-title":"SDF-1\/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy","volume":"75","author":"Jiang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0067","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jbo.2017.10.002","article-title":"Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer","volume":"9","author":"Guan","year":"2017","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1162700","article-title":"A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs","volume":"14","author":"Ammons","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0069","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1158\/1078-0432.CCR-22-2897","article-title":"Preoperative neutrophil-to-lymphocyte ratio and a new inflammatory biomarkers prognostic index for primary retroperitoneal sarcomas: retrospective monocentric study","volume":"29","author":"Fiore","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.fob.2015.08.002","article-title":"Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma","volume":"5","author":"Liu","year":"2015","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jncc.2024.09.001_bib0071","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.cell.2021.04.016","article-title":"Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0072","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood-2012-07-445189","article-title":"Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells","volume":"121","author":"Matsushima","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0073","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s11999-012-2299-2","article-title":"Anti-TGF-\u03b2 antibody combined with dendritic cells produce antitumor effects in osteosarcoma tumor","volume":"470","author":"Kawano","year":"2012","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0074","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1158\/0008-5472.CAN-08-0104","article-title":"Killer dendritic cells link innate and adaptive immunity against established osteosarcoma in rats","volume":"68","author":"Chauvin","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41568-021-00406-5","article-title":"Evolving cancer\u2013niche interactions and therapeutic targets during bone metastasis","volume":"22","author":"Satcher","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0076","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trecan.2018.12.004","article-title":"Bone metastasis: find your niche and fit in","volume":"5","author":"Zhang","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0077","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0078","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0959-8049(97)10134-4","article-title":"Monitoring of bone metastases","volume":"34","author":"Coleman","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0079","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","article-title":"The bone microenvironment invigorates metastatic seeds for further dissemination","volume":"184","author":"Zhang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0080","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.devcel.2021.03.008","article-title":"The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells","volume":"56","author":"Bado","year":"2021","journal-title":"Dev Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0081","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0082","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","article-title":"The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells","volume":"27","author":"Wang","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0083","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10585-015-9710-9","article-title":"Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment","volume":"32","author":"Sosnoski","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.jncc.2024.09.001_bib0084","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-17-1051","article-title":"Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFbRIII\u2013p38MAPK\u2013pS249\/T252RB pathway","volume":"78","author":"Yu-Lee","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/2159-8290.CD-22-0220","article-title":"Bone metastasis initiation is coupled with bone remodeling through osteogenic differentiation of NG2+ cells","volume":"13","author":"Zhang","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jncc.2024.09.001_bib0086","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s43018-021-00179-8","article-title":"Bone marrow NG2+\/Nestin+ mesenchymal stem cells drive DTC dormancy via TGF-\u03b22","volume":"2","author":"Nobre","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0087","first-page":"570","article-title":"The vicious cycle of bone metastases","volume":"2","author":"Guise","year":"2002","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.jncc.2024.09.001_bib0088","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1152>3.0.CO;2-Q","article-title":"Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients","volume":"92","author":"Feuerer","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0089","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","article-title":"TGF-\u03b2 regulation of T cells","volume":"41","author":"Chen","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41422-023-00810-6","article-title":"SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches","volume":"33","author":"Wu","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0091","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kung","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0092","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-02-0474","article-title":"T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG\/TRAIL interaction","volume":"104","author":"Colucci","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0093","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.04-1823fje","article-title":"Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement","volume":"19","author":"Roato","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jncc.2024.09.001_bib0094","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1074\/jbc.M804812200","article-title":"Interferon-\u03b3 targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases","volume":"284","author":"Xu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jncc.2024.09.001_bib0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-\u03b3","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0096","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/jbmr.4615","article-title":"Bone microenvironment-suppressed T cells increase osteoclast formation and osteolytic bone metastases in mice","volume":"37","author":"Arellano","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0097","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4161\/onci.1.2.18480","article-title":"Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer","volume":"1","author":"Zhao","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jncc.2024.09.001_bib0098","doi-asserted-by":"crossref","first-page":"e46342","DOI":"10.1371\/journal.pone.0046342","article-title":"Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration","volume":"7","author":"Karavitis","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jncc.2024.09.001_bib0099","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature09707","article-title":"Tumour-infiltrating regulatory T cells stimulate mammary cancermetastasis through RANKL-RANK signalling","volume":"470","author":"Tan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0100","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2019.10.029","article-title":"Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy","volume":"179","author":"Jiao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0101","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2407-11-365","article-title":"Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer","volume":"11","author":"Roy","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","article-title":"The paradox of Th17 cell functions in tumor immunity","volume":"322","author":"Asadzadeh","year":"2017","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0103","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0104","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2012-08-448548","article-title":"Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans","volume":"121","author":"G\u0308or\u0308gun","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10555-021-09965-3","article-title":"Emerging roles for myeloid immune cells in bone metastasis","volume":"40","author":"Alsamraae","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jncc.2024.09.001_bib0106","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-12-2202","article-title":"Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer","volume":"73","author":"Sawant","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0107","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0108","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI92466","article-title":"Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone","volume":"128","author":"Roca","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jncc.2024.09.001_bib0109","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nm.2830","article-title":"Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape","volume":"18","author":"Bidwell","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0110","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.20150950","article-title":"Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer","volume":"213","author":"D'Amico","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0111","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0112","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0113","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0114","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4161\/onci.21990","article-title":"Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction","volume":"1","author":"Danilin","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jncc.2024.09.001_bib0115","doi-asserted-by":"crossref","first-page":"e94296","DOI":"10.1172\/jci.insight.94296","article-title":"Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer","volume":"2","author":"Dominguez","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jncc.2024.09.001_bib0116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12967-015-0410-7","article-title":"Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer","volume":"13","author":"OuYang","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0117","doi-asserted-by":"crossref","first-page":"e48871","DOI":"10.1371\/journal.pone.0048871","article-title":"Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells","volume":"7","author":"Zhuang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jncc.2024.09.001_bib0118","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and functions of tissue macrophages","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jncc.2024.09.001_bib0119","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nri3088","article-title":"Transcriptional regulation of macrophage polarization: enabling diversity with identity","volume":"11","author":"Lawrence","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0120","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/bloodadvances.2017011304","article-title":"Osteomacs interact with megakaryocytes and osteoblasts to regulate murine hematopoietic stem cell function","volume":"1","author":"Mohamad","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jncc.2024.09.001_bib0121","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/jbmr.4314","article-title":"Neonatal osteomacs and bone marrow macrophages differ in phenotypic marker expression and function","volume":"36","author":"Mohamad","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0122","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1182\/blood-2009-11-253534","article-title":"Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs","volume":"116","author":"Winkler","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0123","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.stem.2016.01.013","article-title":"CD82\/KAI1 maintains the dormancy of long-term hematopoietic stem cells through interaction with DARC-expressing macrophages","volume":"18","author":"Hur","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.12.017","article-title":"OsteoMacs: key players around bone biomaterials","volume":"82","author":"Miron","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jncc.2024.09.001_bib0125","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1359\/jbmr.2000.15.8.1477","article-title":"Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts","volume":"15","author":"Takeshita","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0126","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/jbmr.354","article-title":"Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model","volume":"26","author":"Alexander","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0127","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biomaterials.2017.10.033","article-title":"CD169+ macrophages are critical for osteoblast maintenance and promote intramembranous and endochondral ossification during bone repair","volume":"196","author":"Batoon","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jncc.2024.09.001_bib0128","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.181.2.1232","article-title":"Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo","volume":"181","author":"Chang","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0129","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221007","article-title":"Macrophages promote anti-androgen resistance in prostate cancer bone disease","volume":"220","author":"Li","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191820","article-title":"Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth","volume":"217","author":"Ma","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0131","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","article-title":"GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation","volume":"10","author":"Siddiqui","year":"2022","journal-title":"Bone Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0132","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1593\/neo.09988","article-title":"The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment","volume":"11","author":"Mizutani","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.jncc.2024.09.001_bib0133","doi-asserted-by":"crossref","first-page":"29087","DOI":"10.1074\/jbc.M109.035899","article-title":"Chemokine (C-C Motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone","volume":"284","author":"Lu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jncc.2024.09.001_bib0134","doi-asserted-by":"crossref","first-page":"e13115","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jncc.2024.09.001_bib0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jbo.2016.03.004","article-title":"The role of tumour-associated macrophages in bone metastasis","volume":"5","author":"Sousa","year":"2016","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0136","doi-asserted-by":"crossref","first-page":"e1780","DOI":"10.1038\/cddis.2015.144","article-title":"ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis","volume":"6","author":"Yang","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jncc.2024.09.001_bib0137","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.1074\/jbc.M114.571620","article-title":"Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis","volume":"289","author":"Soki","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jncc.2024.09.001_bib0138","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","article-title":"Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-\u03b2, PGE2, and PAF","volume":"101","author":"Fadok","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jncc.2024.09.001_bib0139","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0140","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1232221","article-title":"Tumor-associated neutrophils display a distinct N1 profile following TGF\u03b2 modulation: a transcriptomics analysis of pro- vs. antitumor TANs","volume":"5","author":"Shaul","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jncc.2024.09.001_bib0141","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13045-019-0836-0","article-title":"Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response","volume":"13","author":"Yang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0142","doi-asserted-by":"crossref","first-page":"361ra138","DOI":"10.1126\/scitranslmed.aag1711","article-title":"Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps","volume":"8","author":"Park","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0143","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","article-title":"DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25","volume":"583","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0144","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1172\/JCI67484","article-title":"Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis","volume":"123","author":"Cools-Lartigue","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jncc.2024.09.001_bib0145","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccell.2023.03.008","article-title":"Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-\u03b2 activation","volume":"41","author":"Mousset","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0146","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0147","doi-asserted-by":"crossref","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jncc.2024.09.001_bib0148","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s12282-021-01270-9","article-title":"CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients","volume":"28","author":"Giorello","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0149","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.4049\/jimmunol.1101855","article-title":"Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells","volume":"189","author":"Sawant","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115755","article-title":"Dendritic cells development into osteoclast-type APCs by 4T1 breast tumor T cells milieu boost bone consumption","volume":"143","author":"Monteiro","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.jncc.2024.09.001_bib0151","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jncc.2024.09.001_bib0152","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0153","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","article-title":"Immune determinants of the pre-metastatic niche","volume":"41","author":"Patras","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0154","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0155","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0156","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","article-title":"Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis","volume":"6","author":"Yang","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0157","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1158\/0008-5472.CAN-07-1882","article-title":"Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma","volume":"67","author":"Melani","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0158","doi-asserted-by":"crossref","first-page":"e22355","DOI":"10.4161\/onci.22355","article-title":"Hypoxia-driven immunosuppression contributes to the pre-metastatic niche","volume":"2","author":"Sceneay","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jncc.2024.09.001_bib0159","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2011.08.012","article-title":"Tumor entrained neutrophils inhibit seeding in the premetastatic lung","volume":"20","author":"Granot","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0160","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.7150\/thno.45351","article-title":"Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells","volume":"11","author":"Yuan","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jncc.2024.09.001_bib0161","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1158\/0008-5472.CAN-21-1331","article-title":"Extracellular vesicle-packaged CDH11 and ITGA5 induce the premetastatic niche for bone colonization of breast cancer cells","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0162","doi-asserted-by":"crossref","first-page":"eaal5081","DOI":"10.1126\/science.aal5081","article-title":"Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils","volume":"358","author":"Engblom","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jncc.2024.09.001_bib0163","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1073\/pnas.1708161114","article-title":"Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis","volume":"114","author":"He","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jncc.2024.09.001_bib0164","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ccell.2018.10.002","article-title":"The osteogenic niche is a calcium reservoir of bone micrometastases and confers unexpected therapeutic vulnerability","volume":"34","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0166","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ccell.2017.11.002","article-title":"Therapeutic antibody targeting tumor- and osteoblastic niche-derived jagged1 sensitizes bone metastasis to chemotherapy","volume":"32","author":"Zheng","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0167","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144579","article-title":"RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis","volume":"132","author":"Yue","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jncc.2024.09.001_bib0168","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116932","article-title":"Cooperation between T and B cells reinforce the establishment of bone metastases in a mouse model of breast cancer","volume":"178","author":"Monteiro","year":"2024","journal-title":"Bone"},{"key":"10.1016\/j.jncc.2024.09.001_bib0169","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0170","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1073\/pnas.1320753111","article-title":"Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jncc.2024.09.001_bib0171","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1158\/0008-5472.CAN-15-0204","article-title":"Activation of hematopoietic stem\/progenitor cells promotes immunosuppression within the pre-metastatic niche","volume":"76","author":"Giles","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0172","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1073\/pnas.1424927112","article-title":"Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils","volume":"112","author":"Casbon","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jncc.2024.09.001_bib0173","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1158\/0008-5472.CAN-13-0842","article-title":"Dysregulated hematopoiesiscausedbymammary Cancer is associated with epigenetic changes and Hox gene expression in hematopoietic cells","volume":"73","author":"Sio","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0174","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stem.2023.04.005","article-title":"Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal","volume":"30","author":"Hao","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0175","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s41556-023-01291-w","article-title":"Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche","volume":"25","author":"Gerber-Ferder","year":"2023","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0176","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/mutage\/gey014","article-title":"Chemotherapy-induced genotoxic damage to bone marrow cells: long-term implications","volume":"33","author":"May","year":"2018","journal-title":"Mutagenesis"},{"key":"10.1016\/j.jncc.2024.09.001_bib0177","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.bmt.1701364","article-title":"Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells","volume":"22","author":"Schwartz","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jncc.2024.09.001_bib0178","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nm.3155","article-title":"Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration","volume":"19","author":"Lucas","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0179","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-018-0859-3","article-title":"Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia","volume":"37","author":"Tang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2643-3230.BCD-19-0028","article-title":"Cytotoxic therapy\u2013induced effects on both hematopoietic and marrow stromal cells promotes therapy-related myeloid neoplasms","volume":"1","author":"Stoddart","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.jncc.2024.09.001_bib0181","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12015-019-09886-3","article-title":"The therapeutic potential of mesenchymal stromal cells in the treatment of chemotherapy-induced tissue damage","volume":"15","author":"R\u00fchle","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jncc.2024.09.001_bib0182","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00277-009-0896-2","article-title":"Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy","volume":"89","author":"Kemp","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0183","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7150\/thno.73152","article-title":"Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitorbased immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jncc.2024.09.001_bib0184","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ccell.2023.05.009","article-title":"Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity","volume":"41","author":"Vennin","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jncc.2024.09.001_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(10)07001-6","article-title":"Breaking tolerance in a mouse model of multiple myeloma by chemoimmunotherapy","volume":"107","author":"Sharabi","year":"2010","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0186","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1158\/0008-5472.CAN-21-3714","article-title":"Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer","volume":"82","author":"Singh","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0187","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2009-11-251231","article-title":"Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs","volume":"115","author":"Nakahara","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jncc.2024.09.001_bib0188","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy","volume":"17","author":"Gibney","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0189","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1470-2045(18)30006-8","article-title":"Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials","volume":"19","author":"D'Angelo","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0191","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00198-023-06690-1","article-title":"Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event","volume":"34","author":"Ye","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jncc.2024.09.001_bib0192","doi-asserted-by":"crossref","first-page":"e14153","DOI":"10.1200\/JCO.2019.37.15_suppl.e14153","article-title":"Combined treatment of patients with bone metastases from various cancers with nivolumab plus denosumab: a retrospective study","volume":"37","author":"Ozaki","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0193","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20987","article-title":"Cytotoxic effects of \u03b3\u03b4 T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy","volume":"116","author":"Sato","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0194","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0195","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1078-0432.CCR-18-2035","article-title":"FDA Approval summary: tisagenlecleucel for treatment of patients with relapsed or refractory b-cell precursor acute lymphoblastic leukemia","volume":"25","author":"O'Leary","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0196","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","article-title":"CAR T cell therapy for solid tumors","volume":"68","author":"Newick","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0197","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf0108","article-title":"\u03b3\u03b4-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer","volume":"9","author":"Frieling","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.jncc.2024.09.001_bib0198","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1380764","article-title":"Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer","volume":"7","author":"Priceman","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jncc.2024.09.001_bib0199","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-022-01726-1","article-title":"PSMA-targeting TGF\u03b2-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial","volume":"28","author":"Narayan","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0200","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","volume":"18","author":"Gill","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0201","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169655","article-title":"Antitumor activity of AZD0754, a dnTGF\u03b2RII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer","volume":"133","author":"Zanvit","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jncc.2024.09.001_bib0202","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/bjc.2011.293","article-title":"Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours","volume":"105","author":"Nicol","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jncc.2024.09.001_bib0203","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jor.21579","article-title":"Sensitization of human osteosarcoma cells to V\u03b39V\u03b42 T-cell-mediated cytotoxicity by zoledronate","volume":"30","author":"Li","year":"2012","journal-title":"J Orthop Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0204","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","article-title":"CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy","volume":"41","author":"Pan","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smim.2017.07.009","article-title":"NK cell-based immunotherapy for cancer","volume":"31","author":"Fang","year":"2017","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13045-020-00983-2","article-title":"Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0207","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/2159-8290.CD-19-0154","article-title":"Infiltrating myeloid cells drive osteosarcoma progression via GRM4 regulation of IL23","volume":"9","author":"Kansara","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jncc.2024.09.001_bib0208","doi-asserted-by":"crossref","first-page":"e23551","DOI":"10.1200\/JCO.2020.38.15_suppl.e23551","article-title":"Phase II trial using haploidentical hematopoietic cell transplantation (HCT) followed by donor natural killer (NK) cell infusion and sirolimus maintenance for patients with high-risk solid tumors","volume":"38","author":"Thakar","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0209","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-023-04061-2","article-title":"M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors","volume":"21","author":"Huo","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0211","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0212","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-10-3126","article-title":"PROVENGE (sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine","volume":"17","author":"Cheever","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0214","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/pros.20040","article-title":"Immunotherapy (APC8015, provenge\u00ae) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a phase 2 trial","volume":"60","author":"Burch","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.jncc.2024.09.001_bib0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jncc.2024.09.001_bib0216","article-title":"Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0217","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00262-015-1731-3","article-title":"A phase I trial combining decitabine\/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma","volume":"64","author":"Krishnadas","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jncc.2024.09.001_bib0218","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1158\/1078-0432.CCR-07-4065","article-title":"A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas","volume":"14","author":"Mackall","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0219","doi-asserted-by":"crossref","first-page":"eabo7868","DOI":"10.1126\/sciadv.abo7868","article-title":"Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.jncc.2024.09.001_bib0220","first-page":"917","article-title":"Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer","volume":"62","author":"Yi","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jncc.2024.09.001_bib0221","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41556-019-0373-7","article-title":"Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms","volume":"21","author":"Kim","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jncc.2024.09.001_bib0222","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102074","article-title":"Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis","volume":"54","author":"Liu","year":"2024","journal-title":"Nano Today"}],"container-title":["Journal of the National Cancer Center"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005424000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005424000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T12:22:49Z","timestamp":1733487769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667005424000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":222,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2667005424000826"],"URL":"https:\/\/doi.org\/10.1016\/j.jncc.2024.09.001","relation":{},"ISSN":["2667-0054"],"issn-type":[{"value":"2667-0054","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoimmunology in bone malignancies: a symphony with evil","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Cancer Center","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jncc.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Chinese National Cancer Center. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}